1 February 2025 in Journal of Neural Engineering
Objective. Local field potential (LFP) recordings using chronically implanted sensing-enabled stimulators are a powerful tool for indexing symptom presence and severity in neurological and neuropsychiatric disorders, and for enhancing our neurophysiological understanding of brain processes. LFPs have gained interest as input signals for closed-loop deep brain stimulation (DBS) and can be used to inform DBS parameter selection. LFP recordings using chronically implanted sensing-enabled stimulators have various implementational challenges. Approach. Here we describe our collective experience using BrainSense (Medtronic®) for clinical and research work. We aim to provide insightful tips and practical advice to empower readers with the knowledge needed to navigate the intricacies of the device and make the most out of its features. Main results. The central issues that apply to several BrainSense features encompass restricted compatibility of stimulation configuration with sensing, differences in electrophysiological signal properties between ‘stimulation OFF’ and ‘stimulation ON at 0.0 mA’, and challenges associated with the internal clock of the neurostimulator. In addition, since recordings are obtained from bipolar and not monopolar channels, spatial certainty regarding the distribution of LFPs around the DBS electrode is limited. Several options exist to synchronize LFP time series with external data streams, but standardization and generalization are lacking. The use of at-home chronic LFP recording is limited by a low temporal and spectral resolution. Regarding at-home LFP snapshots, LFP time series are not stored, parts of the power spectrum are censored when stimulating at high or low frequencies, and the stimulation amplitude is not readily available. Significance. We discussed practical applications, implementation, system limitations, and pitfalls with the aim that sensing can be better applied for clinical practice and research.
29 August 2025 in Annals of Neurology
Objective: In Parkinson's disease (PD), the power of beta oscillations (± 13–30 hertz [Hz]) from subthalamic nucleus (STN) local field potentials (LFPs) is associated with motor symptoms. Beta power can be used for adaptive deep brain stimulation (aDBS) algorithms based upon symptom fluctuations. The time course of beta power modulations after levodopa intake at home remains to be described. Methods: Ten‐minute averages of beta peak power were recorded in 33 patients with PD treated with STN‐DBS for a median duration of 134 days during the titration phase. Median beta power after scheduled medication intakes (n = 24,103) and the effects of peak frequency, stun effect, stimulation amplitude, levodopa dose, and preoperative levodopa response were analyzed using cluster‐based permutation testing. Results: Beta power was significantly reduced between 30 and 140 minutes after intake for stimulation amplitudes between 0 and 2.1 mA ( p < 0.01). This response was seen in low (12.7–20.5 Hz) but not high (21.5–30.3 Hz) beta frequencies. Significant clusters were found regardless of stun effect and preoperative levodopa response, during low stimulation amplitudes (< 1 mA), and for 100 and 150 mg but not 50 mg doses. A linear mixed‐effects model for the area under the curve (AUC) levodopa beta response (30–180 min) revealed a dose–response relationship, a stronger negative response in low‐beta compared with high‐beta frequencies, and no significant effect of stimulation amplitude. Interpretation: STN beta power responds to levodopa during low to moderate stimulation amperages, depending on the beta peak frequency and dose, which is informative for aDBS implementation. ANN NEUROL 2025;98:1352–1363
1 May 2026 in Movement Disorders Clinical Practice
10 March 2026 in Brain Stimulation
11 August 2026 in Brain Stimulation